126 related articles for article (PubMed ID: 25056536)
1. Targeting SMAD3 for inhibiting prostate cancer metastasis.
Xia Q; Li C; Bian P; Wang J; Dong S
Tumour Biol; 2014 Sep; 35(9):8537-41. PubMed ID: 25056536
[TBL] [Abstract][Full Text] [Related]
2. Molecular regulation of ovarian cancer cell invasion.
Sun N; Zhang Q; Xu C; Zhao Q; Ma Y; Lu X; Wang L; Li W
Tumour Biol; 2014 Nov; 35(11):11359-66. PubMed ID: 25119590
[TBL] [Abstract][Full Text] [Related]
3. PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation.
Huang S; Liao Q; Li L; Xin D
Tumour Biol; 2014 Jul; 35(7):6265-70. PubMed ID: 24627133
[TBL] [Abstract][Full Text] [Related]
4. Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.
Dilly AK; Ekambaram P; Guo Y; Cai Y; Tucker SC; Fridman R; Kandouz M; Honn KV
Int J Cancer; 2013 Oct; 133(8):1784-91. PubMed ID: 23526143
[TBL] [Abstract][Full Text] [Related]
5. Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer.
Majumder S; Bhowal A; Basu S; Mukherjee P; Chatterji U; Sengupta S
J Cell Physiol; 2016 Nov; 231(11):2482-92. PubMed ID: 26919443
[TBL] [Abstract][Full Text] [Related]
6. Golgi phosphoprotein 3 regulates metastasis of prostate cancer via matrix metalloproteinase 9.
Li W; Qi K; Wang Z; Gu M; Chen G; Guo F; Wang Z
Int J Clin Exp Pathol; 2015; 8(4):3691-700. PubMed ID: 26097550
[TBL] [Abstract][Full Text] [Related]
7. RNA interference mediated suppression of TRPV6 inhibits the progression of prostate cancer
Kim DY; Kim SH; Yang EK
Investig Clin Urol; 2021 Jul; 62(4):447-454. PubMed ID: 34085788
[TBL] [Abstract][Full Text] [Related]
8. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.
Uygur B; Wu WS
Mol Cancer; 2011 Nov; 10():139. PubMed ID: 22074556
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics.
Zhang J; Wang J; Luan T; Zuo Y; Chen J; Zhang H; Ye Z; Wang H; Hai B
Oncol Rep; 2019 Jun; 41(6):3292-3304. PubMed ID: 31002345
[TBL] [Abstract][Full Text] [Related]
10. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness.
Matsuura I; Lai CY; Chiang KN
Biochem J; 2010 Feb; 426(3):327-35. PubMed ID: 20070253
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface.
Desai B; Ma T; Zhu J; Chellaiah MA
J Cell Biochem; 2009 Sep; 108(1):272-84. PubMed ID: 19582779
[TBL] [Abstract][Full Text] [Related]
13. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
Johnson TR; Koul S; Kumar B; Khandrika L; Venezia S; Maroni PD; Meacham RB; Koul HK
Mol Cancer; 2010 Jun; 9():148. PubMed ID: 20550708
[TBL] [Abstract][Full Text] [Related]
14. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
Nalla AK; Gorantla B; Gondi CS; Lakka SS; Rao JS
Cancer Gene Ther; 2010 Sep; 17(9):599-613. PubMed ID: 20448670
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor SPDEF suppresses prostate tumor metastasis.
Steffan JJ; Koul S; Meacham RB; Koul HK
J Biol Chem; 2012 Aug; 287(35):29968-78. PubMed ID: 22761428
[TBL] [Abstract][Full Text] [Related]
16. Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45.
Guo LY; Li YM; Qiao L; Liu T; Du YY; Zhang JQ; He WT; Zhao YX; He DQ
World J Gastroenterol; 2012 Dec; 18(48):7262-70. PubMed ID: 23326131
[TBL] [Abstract][Full Text] [Related]
17. ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression.
Kato T; Fujita Y; Nakane K; Kojima T; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2012 Jan; 417(3):966-71. PubMed ID: 22206665
[TBL] [Abstract][Full Text] [Related]
18. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.
Wang F; Xiao W; Sun J; Han D; Zhu Y
Tumour Biol; 2014 Sep; 35(9):8653-8. PubMed ID: 24867100
[TBL] [Abstract][Full Text] [Related]
20. TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.
Zhu J; Yang DR; Sun Y; Qiu X; Chang HC; Li G; Shan Y; Chang C
Mol Cancer Ther; 2015 Jun; 14(6):1445-53. PubMed ID: 25833838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
